Influenza

S. pneumoniae testing is critical to diagnose secondary bacterial pneumonia infections

As concern over the potential mutation of the latest form of influenza virus continues to vex governments and their healthcare organisations, WHO 2009 data has shown that acute respiratory infections, influenza and respiratory syncitial virus (RSV) epidemics coincide with epidemics of S. pneumoniae. In fact, half or more of flu-associated mortality in the 1918-1919 Spanish Flu epidemic is believed to have resulted from pneumococcal super-infections.

Photo: Influenza

Therefore, during high influenza infection periods it becomes vital to diagnose and reduce the complications of secondary bacterial infections by rapid testing for S. pneumoniae . The BinaxNOW S. pneumoniae test from Inverness Medical, for example, is a 15 minute in vitro immunochromatographic assay to detect S. pneumoniae antigen in the urine of patients with pneumonia, to be used in conjunction with culture and other methods. ‘The easy-to-use, urine-based test allows targeted antibiotic treatment within four hours of admission, enabling improved patient outcomes and lower overall healthcare costs,’ the manufacturer reports, referring to Houck PM et al. Arch Intern Med. 2004 Mar 22; 164 (6):637-44.
‘Urinary antigen testing for S. pneumoniae has several advantages over conventional microbiology testing for the diagnosis of community acquired pneumonia (CAP). Sputum samples are difficult to obtain and the yield of both sputum gram stain and culture can be limited particularly if the patient has commenced antibiotic treatment.’

It has been recommended that urinary antigen testing for S. pneumoniae be incorporated into the testing algorithms of Country specific Guidelines for the Management of Community Acquired Pneumonia (L Mandell et al. published in Clinical Infectious Diseases 2007; 44: S27-72).

Massachusetts-based Inverness Medical focuses on products for infectious disease control, cardiology, oncology, drugs of abuse and women’s health. To discuss the importance of rapid testing for respiratory infections, including influenza A and B, S. pneumoniae, Legionella, RSV and the product BinaxNOW S. pneumoniae, visit the company’s stand.

Inverness at Medica
Hall 3. Stand C70
www.invmed.com

16.11.2009

Read all latest stories

Related articles

Nobel scientist urges wider vaccination against HPV infection

A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, predicted…

Photo

Silenced genes as a warning sign of blood cancer

In the genetic material of cancer cells, important growth inhibitors are often switched off by chemical labels in the DNA. Scientists of the German Cancer Research Center and the Ohio State…

Photo

Pandemic panic sends feathers flying

AIDS, SARS and now H5NI; just a brief beginning or the end? As the virus moves towards Europe, and millions of birds are slaughtered, interest has risen in a Chinese herb, a patent-sharing…

Related products

i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Medat – Laboratory Information System

LIS, Middleware, POCT

Medat – Laboratory Information System

Medat Computer-Systeme GmbH
Siemens Healthineers - syngo Lab Inventory Manager (sLIM)

LIS, Middleware, POCT

Siemens Healthineers - syngo Lab Inventory Manager (sLIM)

Siemens Healthineers
Agfa HealthCare – Dose

Dose Management Systems

Agfa HealthCare – Dose

Agfa HealthCare
Agfa HealthCare – DR 14e detector

DR Retrofit

Agfa HealthCare – DR 14e detector

Agfa HealthCare
Agfa HealthCare – DR 17e detector

DR Retrofit

Agfa HealthCare – DR 17e detector

Agfa HealthCare